XNCR Dividend History & Analysis | N/A Yield
XNCR has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 24.9% | 0.31% |
| ABBV | 400,779 M | 2.87% | 9.50% |
| GILD | 145,398 M | 2.59% | 6.37% |
| AMGN | 159,253 M | 3.17% | 4.89% |
| HLN | 40,587 M | 1.86% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 8,431 M | 127% | 60.7% |
| HLN | 40,587 M | 51.0% | 100% |
| AMGN | 159,253 M | 8.90% | 100% |
| ABBV | 400,779 M | 7.06% | 100% |
| GILD | 145,398 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare XNCR Dividends with its Peer-Group
2.87% Yield
3.17% Yield
2.59% Yield
1.86% Yield
XNCR Dividend History: as of October 2025
No dividends paid yet.XNCR Dividend FAQ
Xencor Inc. (NASDAQ: XNCR) is a clinical-stage biopharma that engineers monoclonal antibodies using its XmAb™ platform. Its marketed assets include Ultomiris (atypical hemolytic uremic syndrome, generalized myasthenia gravis, neuromyelitis optica spectrum disorder), Monjuvi (relapsed/refractory diffuse large B-cell lymphoma) and the antiviral Sotrovimab. The pipeline spans multiple bispecific antibodies-XmAb819 (renal cell carcinoma), XmAb541 (ovarian cancer), Vudalimab (metastatic castration-resistant prostate cancer), XmAb564 (autoimmune disease), and Plamotamab (lymphoma)-as well as T-cell engagers, Fc-engineered candidates, and viral therapeutics.
What is the Dividend Yield of XNCR?
As of October 2025, XNCR`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 13.29.Does XNCR pay a dividend?
As of October 2025 XNCR does not pay a dividend.How often does XNCR pay dividends?
Over the last 12 months, XNCR has issued dividend payments.Will XNCR pay dividends in 2025?
The next Ex-Dividend date for Xencor (XNCR) is currently unknown.What is the next Ex-Dividend Date for XNCR?
The next Ex-Dividend date for Xencor (XNCR) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of XNCR?
XNCR's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of XNCR?
XNCR's 5-Year Yield on Cost is -%. If you bought XNCR's shares at 39.40 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of XNCR?
XNCR Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does XNCR have a good Dividend Yield?
XNCR`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of XNCR?
The Dividend Payout Ratio of XNCR is unknown.What is the Dividend Rating of XNCR?
XNCR`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-17 04:47